Litcius/Paper detail

First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician

Sam S. Chang, David Hudesman

2020Current Gastroenterology Reports31 citationsDOI

Topics & Concepts

VedolizumabMedicineUstekinumabInfliximabAdalimumabInflammatory bowel diseaseTofacitinibUlcerative colitisCrohn's diseaseIntensive care medicineDiseaseDermatologyInternal medicineRheumatoid arthritisInflammatory Bowel DiseaseMicroscopic ColitisPregnancy and Medication Impact
First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician | Litcius